Illumina Inc. has agreed to pay $9.8 million to resolve allegations that it violated the False Claims Act when it sold to federal agencies certain genomic sequencing systems with cybersecurity vulnerabilities. Illumina is a Delaware corporation, headquartered in California, that manufactured and sold genomic sequencing systems throughout the United States. Read More
Home » Illumina Inc. to Pay $9.8M to Resolve False Claims Act Allegations
Illumina Inc. to Pay $9.8M to Resolve False Claims Act Allegations
Related Posts
California Defense Contractor and Private Equity Firm Agree to Pay
Defense contractor Aero Turbine Inc., of Stockton, California, and private equity company Gallant Capital Partners LLC, of Los Angeles, have agreed to pay $1.75 million… BronCalifornia Defense Contractor and Private Equity Firm Agree to Pay
U.S. Department of Justice Announces Compensation Process for Victims
Today, the Department of Justice announced the launch of the Backpage remission process to compensate victims whose trafficking was facilitated through the Backpage.com website. This… BronU.S. Department of Justice Announces Compensation Process for Victims
Dermatology Providers Agree to Pay Nearly $850,000 to Resolve
Forefront Dermatology S.C. and Henghold Surgery Center LLC, have agreed to pay $847,394 to resolve allegations that they violated the False Claims Act by knowingly… BronDermatology Providers Agree to Pay Nearly $850,000 to Resolve